Clinical Trial Update: A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1 [Phase 3]

View source ↗

Summary

Phase 3 trial results for lumasiran in children and adults with Primary Hyperoxaluria Type 1 have been completed, with results posted in January 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria Type

Drugs mentioned

• Oxlumo (lumasiran)

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Primary Hyperoxaluria Type 1 (PH1) | Phase 3 | Status: COMPLETED | Results posted: 2021-01-19